About
Our vision is to enable rapid and local tests for anticoagulants at the point-of-care to benefit patients. Currently, there is no readily available solutions to address blood levels of anticoagulants called Direct Oral Anticoagulants (DOACs) at the point-of-care. We have developed a novel technology, chip and instrument that can detect anticoagulants, directly from whole blood within only 10 minutes. The elegant simplicity of our solution will potentially be readily available at the point of care.
Technologies
Outlook
Microsoft Office 365
Amazon AWS
reCAPTCHA
Mobile Friendly
Wix
Keywords
medical equipment manufacturing
healthcare equipment & supplies
risk assessment
life-saving therapies
lab-quality accuracy
medical device development
emergency stroke treatment tools
blood sample complex media
user usability studies
anticoagulant drugs
blood sample cartridge technology
emergency healthcare
blood sample analysis
rapid diagnostic platform
lab-grade accuracy
blood sample processing
dna nanotechnology diagnostics
point-of-care anticoagulant testing
dna nanotech platform
clinical validation
medical equipment and supplies manufacturing
b2b
emergency medicine tools
multi-center clinical studies
medical technology
medical devices
multi-country clinical validation
cartridge system
blood-based small molecule detection
diagnostic accuracy
Company Information
-
Employees 13
-
Founded 2019
Location
85 Universitetsbyen, Aarhus, Central Denmark Region, Denmark, 8000
